Interestingly, a closely related tracer to [18F]PARPi, [18F]FTT, has already shown a link between higher pre-treatment tracer uptake and better therapeutic outcomes for breast cancer patients receiving PARP inhibitor therapy [52]. Here, PARP1 is linked to breast cancer.